<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04172285</url>
  </required_header>
  <id_info>
    <org_study_id>EXERSARCO</org_study_id>
    <nct_id>NCT04172285</nct_id>
  </id_info>
  <brief_title>Physical Activity Program for Counteracting Sarcopenia</brief_title>
  <acronym>EXERSARCO</acronym>
  <official_title>Effects of an Home-base Physical Activity Program for Counteracting Sarcopenia in Elderly: a Randomized-controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istituto Ortopedico Galeazzi</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istituto Ortopedico Galeazzi</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sarcopenia is a pathophysiological process associated with aging and some metabolic&#xD;
      conditions characterized by progressive muscle tissue loss, which may lead to loss of&#xD;
      strangth and performance and increase risk of falls and fractures, physical disability and&#xD;
      premature death. Therefore, it is necessary to identify personalized programs of physical&#xD;
      activity and supplementation for elderly population in order to improve their physical&#xD;
      functions, muscle strengh and body composition.&#xD;
&#xD;
      With the present project we aime to assess the effect of a feasible home-based exercise&#xD;
      program coupled with food supplementation to improve muscle strength, muscle volume and&#xD;
      muscle physical performance potentially associated with sarcopenia in elderly people.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">September 18, 2019</start_date>
  <completion_date type="Anticipated">December 20, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 20, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Lower limb strength</measure>
    <time_frame>Baseline and Week 24</time_frame>
    <description>Assessed by chair stand test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Body composition</measure>
    <time_frame>Baseline and Week 24</time_frame>
    <description>Assessed by Whole-body dual energy X-ray absorptiometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quantify thigh cross sectional area</measure>
    <time_frame>Baseline and Week 24</time_frame>
    <description>Assessed by Dixon magnetic resonance imaging</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximum isometric force that a hand can squeeze</measure>
    <time_frame>Baseline and Week 24</time_frame>
    <description>Assessed by Hand Grip Strength test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximal Isometric Strength of Knee flexors and extensors</measure>
    <time_frame>Baseline AND Week 24</time_frame>
    <description>Assessed by a belt-stabilized dynamometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dynamic balance and gait deficits</measure>
    <time_frame>Baseline and Week 24</time_frame>
    <description>Assessed by mini-BESTest</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">16</enrollment>
  <condition>Sarcopenia</condition>
  <arm_group>
    <arm_group_label>Physical activity group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Physical activity and supplementation group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Physical activity</intervention_name>
    <description>Home-based physical activity program</description>
    <arm_group_label>Physical activity group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Physical activity and supplementation</intervention_name>
    <description>Home-based physical activity program and amminoacid supplementation</description>
    <arm_group_label>Physical activity and supplementation group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>No intervention</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Sedentary lifestyle.&#xD;
&#xD;
          -  Cognitively intact.&#xD;
&#xD;
          -  Autonomous walking.&#xD;
&#xD;
          -  Acceptance of informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Body mass index lower than 18.5 and uppen than 40 kg/m2.&#xD;
&#xD;
          -  History of cancer.&#xD;
&#xD;
          -  Pacemaker user.&#xD;
&#xD;
          -  History of epileptic episodes.&#xD;
&#xD;
          -  Endocrine-metabolic, neurological, muscular and ortopedic pathologies that affect&#xD;
             movement functions.&#xD;
&#xD;
          -  Bone fractures that influence movement functions.&#xD;
&#xD;
          -  Smoking.&#xD;
&#xD;
          -  Surgical treatments in the prior 6 months.&#xD;
&#xD;
          -  Use of antieptilectics, glucocorticoids, rhGH and testosterone.&#xD;
&#xD;
          -  Hepatic and muscular pathologies&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>IRCCS Istituto Ortopedico Galeazzi</name>
      <address>
        <city>Milan</city>
        <zip>20141</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>November 13, 2019</study_first_submitted>
  <study_first_submitted_qc>November 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 21, 2019</study_first_posted>
  <last_update_submitted>February 8, 2021</last_update_submitted>
  <last_update_submitted_qc>February 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sarcopenia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

